Balanced product information

Evidence, limitations and safety — in one consistent format.

This page separates authorised uses from investigational or reported uses. It does not provide personal medical advice or dosing instructions.

Last content review12 September 2026
01

Product name

Testosterone cypionate (TRT) 600mg injection pen kit

Catalogue formatInjection Pen Kit
Displayed strength600mg
UK contextPrescription-only medicine context; HELIX presentation not verified as UK-authorised

Catalogue label details describe what is displayed; they do not independently verify composition, quality, batch release or UK marketing authorisation.

02

What is it?

Testosterone cypionate is an injectable ester of testosterone, an androgen hormone. Testosterone medicines may be used in replacement therapy when clinically significant deficiency is confirmed by symptoms and laboratory testing.

This HELIX catalogue entry describes the displayed TRT 600mg pen-kit presentation and packaging information. It does not independently verify the product's composition, batch release, sterility, quality, suitability or UK marketing authorisation.

03

Intended / recognised uses

Authorised / recognised uses

  • Specific testosterone medicines are authorised for testosterone replacement in men with confirmed hypogonadism, according to the individual product licence and professional assessment.
  • Treatment decisions usually require repeat morning testosterone measurements, compatible symptoms and review of contraindications and monitoring needs.

Reported / non-authorised uses

  • Use for bodybuilding, performance enhancement, normal ageing, self-directed hormone optimisation or treatment based only on symptoms is not an authorised replacement indication.
  • The HELIX-labelled TRT 600mg pen-kit presentation has not been verified here as an authorised UK medicine.
04

How it works

Testosterone binds androgen receptors and influences sexual function, muscle and bone, red-blood-cell production, mood, skin, hair follicles and other tissues.

Testosterone cypionate is designed to release testosterone over time after injection; actual pharmacokinetics depend on the licensed product, formulation, route and patient factors.

05

Potential benefits / effects

  • In confirmed hypogonadism, appropriately prescribed and monitored testosterone replacement may improve deficiency-related sexual symptoms, bone health, body composition, anaemia, mood or wellbeing in some patients.
  • Benefits are not guaranteed and depend on diagnosis, dose, monitoring, comorbidities and whether the treatment is clinically appropriate.
  • The displayed HELIX presentation itself is not evidence of safety, efficacy or regulatory approval.

Potential benefit is not a guarantee of benefit for any individual.

06

Risks & warnings

  • Testosterone can raise haematocrit, affect blood pressure, fluid retention, fertility, acne, mood, sleep apnoea, prostate monitoring and cardiovascular or thrombotic risk.
  • Incorrect self-administration, excessive dosing, contaminated products or unverified supply can create serious safety risks.
  • A click guide is not a prescribing instruction; dose and schedule must be set and monitored by an appropriately qualified healthcare professional.
07

Possible side effects

Common or recognised effects

  • Acne or oily skin, injection-site reactions, headache, mood or libido changes, weight or fluid gain and increased red-blood-cell measures may occur with testosterone.
  • Hair changes, breast tenderness or enlargement, testicular shrinkage and reduced fertility can occur.

Serious or urgent concerns

  • Chest pain, sudden breathlessness, one-sided leg swelling, neurological symptoms, severe swelling, severe allergic reaction or prolonged painful erection requires urgent medical care.
  • High haematocrit, abnormal liver tests, marked blood pressure changes or prostate-related concerns require professional review.
08

Who should not use it / precautions

  • Testosterone is contraindicated or inappropriate in several situations, including known or suspected prostate cancer or male breast cancer, pregnancy, breastfeeding and androgen-sensitive conditions.
  • High haematocrit, severe untreated sleep apnoea, significant heart, liver or kidney disease, thrombophilia, fertility goals, prostate symptoms and use in adolescents require specialist advice.
  • Do not use any injectable medicine if identity, sterility, expiry, storage or authenticity cannot be verified.
09

Interactions

  • Testosterone can increase the effect of coumarin anticoagulants and may alter requirements for insulin or other diabetes medicines.
  • Corticosteroids or ACTH used with testosterone may increase fluid retention.
  • All hormones, supplements, performance-enhancing substances and prescribed medicines should be disclosed to the supervising clinician.
10

Regulatory / legal status

  • Authorised testosterone medicines are prescription-only and have product-specific indications, strengths, excipients and administration instructions.
  • No UK marketing authorisation has been verified here for this HELIX TRT 600mg pen-kit presentation.
  • Displaying the product on this website is educational information only and is not an offer for sale or a recommendation to use it.
11

Monitoring / professional supervision

  • Testosterone therapy normally requires compatible symptoms and repeat morning blood tests before treatment is considered.
  • Monitoring may include testosterone level, full blood count/haematocrit, blood pressure, prostate assessment and PSA where appropriate, lipids, liver function, glucose and review of fertility goals.

Labelled TRT click-volume guide

Clicks5 clicks
Volume0.05 mL
Amount10 mg
Clicks10 clicks
Volume0.10 mL
Amount20 mg
Clicks15 clicks
Volume0.15 mL
Amount30 mg
Clicks20 clicks
Volume0.20 mL
Amount40 mg
Clicks25 clicks
Volume0.25 mL
Amount50 mg
Clicks30 clicks
Volume0.30 mL
Amount60 mg
Clicks35 clicks
Volume0.35 mL
Amount70 mg
Clicks40 clicks
Volume0.40 mL
Amount80 mg
Clicks45 clicks
Volume0.45 mL
Amount90 mg
Clicks50 clicks
Volume0.50 mL
Amount100 mg

This table is a labelled pen-volume reference only. It is not personal dosing advice, and medical assessment/professional supervision is required before any use.

12

Evidence & sources

Sources are selected for regulatory status, recognised uses and material safety information. They do not validate the HELIX-labelled presentation.

  1. Electronic Medicines Compendium — Sustanon 250 SmPC
  2. BNF — Testosterone
  3. NHS specialist service — Testosterone replacement therapy
  4. NICE CKS — Male hypogonadism

Sources accessed and content reviewed 12 September 2026. Regulatory status can change; consult the current official record.

13

Information disclaimer

HELIX — FOR INFORMATION ONLY. NOT FOR SALE.

The products displayed on this website are presented strictly for informational and educational purposes, helping visitors understand their descriptions, features and specifications. No products are offered for sale through this website, and no product orders or payments are accepted through this platform.

The information on this website does not constitute medical advice, a prescription or a recommendation to use any product. Displaying a product does not establish its regulatory approval, safety or suitability for an individual. Please consult an appropriately qualified healthcare professional for personal medical advice.

For a UK-facing website, this disclaimer does not by itself establish legal compliance. Public advertising of prescription-only medicines and advertising of unlicensed medicines are subject to legal restrictions; the catalogue, wording and presentation require appropriate regulatory review.

14

Licensed-provider information

Where permitted by applicable law, HELIX may display contact details for independent third-party providers whose registration details have been checked against an appropriate official register. Visitors may contact a listed provider directly to enquire about lawful availability and eligibility requirements.

Any supply is subject to the provider’s assessment, applicable regulations, and verification of all required documentation, which may include a valid prescription, professional licence, identification or other authorisation. A referral does not guarantee availability, eligibility or supply.

Registration status can change. Review the provider's regulator, registration number, official-register record and last-checked date, then verify the current status independently before engaging.